Biopharma Business

Tag "Ledaga"

Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer

Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the progression of a rare form of skin cancer. After being acquired by Johnson & Johnson

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here